Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | IDH1 | O75874 | 8/20 | 0.41 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.40 |
| ▸ | IL6ST | P40189 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1915789 | 1.00 | PPARA (0.42) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL16681720 | 0.92 | PPARA (0.40) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL16681721 | 0.92 | PPARA (0.40) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL29516311 | 0.89 | PPARA (0.43) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL9947401 | 0.89 | CHRM1 (0.48) | PPARAIDH1CHRM1 | |
| SCHEMBL8555423 | 0.88 | GAA (0.46) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL8555074 | 0.86 | PPARA (0.47) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL5160832 | 0.85 | CYP2C19 (0.46) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL5160821 | 0.85 | CYP2C19 (0.46) | PPARAIDH1AGTR2IL6STNAAA | |
| SCHEMBL6421893 | 0.85 | CYP2C19 (0.46) | PPARAIDH1AGTR2IL6STNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2364297-A1 | Compounds, pharmaceutical composition and methods for use in treating metabolic disorders | Euroscreen S.A. (BE) | 2011-09-14 | — | — | EP | disclosed |
| WO-2011076734-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING INFLAMMATORY DISEASES | EUROSCREEN S.A. (BE) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011076732-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING GASTROINTESTINAL DISORDERS | EUROSCREEN S.A. (BE) | 2011-06-30 | — | — | WO | disclosed |
| WO-2010066682-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS | EUROSCREEN S.A. (BE) | 2010-06-17 | — | — | WO | disclosed |